Mototsugu Muramaki

Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells

Masayuki Kamada, Alan So, Mototsugu Muramaki et al. · Molecular Cancer Therapeutics · 2007 · 188 citations

Medicine, Oncology, Pharmacology +12

Risk Factors for Intravesical Recurrence After Surgical Management of Transitional Cell Carcinoma of the Upper Urinary Tract

Tomoaki Terakawa, Hideaki Miyake, Mototsugu Muramaki et al. · Urology · 2008 · 91 citations

Medicine, Surgery, Urology +14

Expression of potential molecular markers in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy

Hideaki Miyake, Mototsugu Muramaki, Toshifumi Kurahashi et al. · Urologic Oncology Seminars and Original Investigations · 2008 · 76 citations

Medicine, Oncology, Urology +17

Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension

Toshifumi Kurahashi, Mototsugu Muramaki, Kazuki Yamanaka et al. · British Journal of Urology · 2005 · 72 citations

Veterinary Medicine, Oncology, Cellular Pathology +7

GLI2 Knockdown Using an Antisense Oligonucleotide Induces Apoptosis and Chemosensitizes Cells to Paclitaxel in Androgen-Independent Prostate Cancer

Shintaro Narita, Alan So, Susan Ettinger et al. · Clinical Cancer Research · 2008 · 71 citations

Medicine, Oncology, Urology +17